Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.870
0.00 (0.00%)
At close: Nov 22, 2024, 4:00 PM
1.900
+0.030 (1.60%)
After-hours: Nov 22, 2024, 7:54 PM EST
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $91.40 million as of November 22, 2024. Its market cap has decreased by -85.73% in one year.
Market Cap
91.40M
Enterprise Value
-76.39M
1-Year Change
-85.73%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has decreased from $235.53M to $91.40M, a decrease of -61.19%. That is a compound annual growth rate of -17.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 110.46M | -88.64% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | 300.21M | -10.59% |
| Dec 31, 2019 | 335.76M | 42.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediciNova | 94.66M |
| Veru Inc. | 94.18M |
| Assembly Biosciences | 93.76M |
| EDAP TMS | 93.13M |
| Regulus Therapeutics | 92.58M |
| OptimizeRx | 90.63M |
| Nuvectis Pharma | 90.47M |
| Assertio Holdings | 90.22M |